BRD4 reduces MHC I expression and antigen processing in the context of cancer, and BRD4 activity may promote tumor progression by increasing chemokine-mediated recruitment of myeloid cells to the tumor (7, 8). This evidence concerns the gene BRD4 and neoplasm.